Laurus Labs Ltd

LAURUSLABS

Company Profile

  • Business description

    Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. The company generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.

  • Contact

    Road No.1, Jubilee Hills
    Plot No.103
    HyderabadTG500033
    IND

    T: +91 4039804333

    https://www.lauruslabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    7,059

Stocks News & Analysis

stocks

ASX share undervalued as margins expected to rebound

This ASX share remains overlooked despite a strong outlook.
stocks

Cheap retail REIT with an attractive yield

Lower consumer spending unlikely to buckle this retail REIT.
stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,185.9070.200.77%
CAC 408,466.8519.580.23%
DAX 4024,914.524.110.02%
Dow JONES (US)51,999.67328.640.64%
FTSE 10010,485.568.65-0.08%
HKSE24,312.16181.79-0.74%
NASDAQ26,376.34307.60-1.15%
Nikkei 22569,902.25497.750.72%
NZX 50 Index13,392.9833.15-0.25%
S&P 5007,511.3542.94-0.57%
S&P/ASX 2008,966.3065.500.74%
SSE Composite Index4,108.0816.180.40%

Market Movers